FDA declines to approve Adamis Pharma's Zimhi to treat opioid overdose

Adamis Pharmaceuticals Corp said on Monday its opioid overdose treatment was rejected by the U.S. Food and Drug Administration.

from Reuters: Health News https://ift.tt/37xvzcF
via IFTTT